Background & justification
The three major Soil-Transmitted Helminths of humans (STH's), Ascaris lumbricoides 
Objectives Overall Objective
The overall objective is to develop and validate a standard protocol to monitor efficacy of anthelmintics of Soil Transmitted Helminths (STH) in populations with different exposure to anthelmintics.
Primary objectives
1. To assess the change in Faecal Egg Counts (FEC) 
Study sites and population

Study sites
A total of 7 countries were selected by the working group: Brazil (Minas Gerais State), Cambodia (Kratie), Cameroon (Loum and Yoyo), Ethiopia (Jimma), India (Vellore, Thiruvanamalai), Tanzania (Zanzibar, Pemba Island), Vietnam (Thái Nguyên, Tuyên Quang).
Selection criteria considered by the group in choosing the study sites were:
 The ability of the sites to perform the studies e.g. presence of equipped diagnostic facilities, skilled personnel  A documented history of presence of STH  A known history of drug selection pressure: high, low or none.
Study Population
Schoolchildren between 6 and 18 years old are the focus of this study because of two main reasons:
1. Schoolchildren are the most accessible group. In countries where school enrolment rates are good the group can be easily reach through the school system (Partnership For Child Development, 1999) , in area where enrollment is not high non-enrolled siblings could be effectively outreached by promoting advocacy through the schools (Montresor et al., 2001) . Therefore it is considered that in each country where resistance to benzimidazole is suspected, this group will be the easier one to be investigated.
2. Schoolchildren are the one that more probably could harbor resistant species of STH.
Children of primary school age (6 -18 years) are normally a major target for regular treatment with anthelminthic, because they are the group that usually has the heaviest worm burdens for A. lumbricoides and T. trichiura, and are steadily acquiring hookworm infections. In addition, they are in a period of intense physical and intellectual growth (Bundy et al. 1992; Crompton and Nesheim, 2002) . Deworming school-age children has a considerable benefit on their nutritional status (Stoltzfus et al., 1996 , Curtale et al., 1995 , physical fitness, appetite, growth (Stephenson et al., 1993) and intellectual development (Nokes et al 1994) .
Ethical issues
The overall protocol of the study has been reviewed by the Ethics committee of the Faculty For each proposed study a separate ethical clearance will be obtained. 
Parasitological technique to determine FEC
Efficacy study
Experimental design
Following obtaining informed consent, schoolchildren in the target age range group will be recruited and asked to provide a recent stool sample (an interval of less that 4 hours) that will be processed to determine the FEC for each STH present. A small subsample of faecal samples will be also collected for coproculture to identify the hookworms species present and preserve parasite material for subsequent analysis (Annex 2.3).
All children providing stool samples will be treated with Albendazole (GSK) single table of 400mg under supervision (chewing + water). The Albendazole will be provided (free) by the coordinating group.
14 to 30 days after treatment a second faecal sample will be collected from the children to determine again FEC. Only children infected with a minimum of 150 eggs/gram of any species of STH (i.e. Ascaris or hookworms or Trichuris) at the first sampling should be included in the second sampling. However, for the other STH present FEC should also be determined at the second sampling.
Sample size
The initial number of schoolchildren to sample will depend on the prevalence of the STH in the study region as a minimum of 250 infected children 1 with a minimum of 150 eggs/gram of any species of STH (i.e. Ascaris or hookworms or Trichuris) should be recruited at each study site e.g. with an expected prevalence of 50% for any specific STH 500 schoolchildren should be enrolled in the first sampling.
If Both CR and ERR will be considered to monitor to efficacy.
To avoid distortion due to the density dependant effect, the CR and ERR will be also calculated separately in the different classes of intensity at baseline. The following indexes should be used to monitor drug efficacy:
Cure rate
[N egg positive post-treatment / N egg positive pre-treatment]*100
Where T1 = pre-treatment FEC, T2 = post-treatment FEC, and i = the ith subject.
Mean percentage FEC ∆ per individual
Percentage ∆ in the sample mean FEC {[sample mean T1-sample mean T2] / sample mean T1 }*100
Confidence intervals for these indexes can be generated by a standard method for proportions in the case of cure rate (the exact binomial method) and by bootstrap resampling methodologies for the FEC ∆ indexes. 
Consent Form
Albendazole against worm infections in …….children We are conducting a study to find the best way of treating children in ……. for intestinal worms. Intestinal worms are very common here and make children anaemic and reduce their growth. You may know there is a National Control Programme in …… that distributes deworming tablets and to all children in schools every six months.
Doctors from the Ministry of Health, and from The World Health Organization (Geneva), need to carry out a study to see how well the deworming drugs are working to cure the worms infections in ……. children. The drug is called Albendazole and it is given in the form of a tablet that children chew with a drink of water. We are asking children aged between 5-14 years from some schools to participate. The school your child is going to has been one of the schools chosen for this study.
After agreeing that your child can take part, one of the research staff will visit the school on a certain day and give your child a small plastic container and ask him/her to produce a sample of his/her faeces. The plastic container with the stool will be collected the next morning in the school.
We will check the stool to see if your child has worms and we will provide him/her treatment. This will make your child healthier. Sometimes a child may experience a minor side effect after taking a tablet of albendazole. These effects, if they occur, include headache, feeling dizzy, itching and nausea. They last for a short time and disappear by themselves. In case of any persistent problem you are advised to refer your child to the nearest Health Centre where staff has been trained and medication are available for this purpose.
After 14 days, we will ask your child to give another faeces sample to see how well the drug has worked against the worms. The faecal samples positives with worms will be stored in the laboratory in case other tests need to be carried out. At the end of the study they will be disposed of by a safe procedure. Some information about your child will be recorded on anonymous forms that will be kept in a locked room at the office in ……….. Only the researchers doing the study will use these forms.
If you have any questions about the study at any time, you can call the Project Manager Dr ………………… at………………, (Phone ………………..).
After the study, all the results of the deworming study will be presented in a public meeting in your child's school by Ministry of Health staff.
We assure you that our best care will be taken of your child if you agree to let him/her take part in the study. You should also know that you are free to withdraw your child from the study at any time and that he/she will not be discriminated in any form for education or health services.
I have read the information above, or it has been read to me. I have been given the opportunity to ask questions and my questions have been answered to my satisfaction. I voluntarily consent that my child participates in this study.
I agree to enroll my child in this study:
Date…………… Signature………………………………………
Ethical considerations
Ethical Committee Review An overall Ethical clearance for the study was obtained from the Human Research Ethics Committee of the University of Ghent, is submitted at the Queensland Institute for Medical Research, and from the respective research ethics committees of the 6 Countries (Brazil, Cameroun, India, Vietnam, Zanzibar & Ethiopia) involved in this multicentric study.
Informed consent and enrolment
The Principal Investigators will prepare an Informed Consent Document and submit it to National research ethics committees of the respective countries, and to the Human Research Ethics Committee of the University of Ghent for approval. The consent form will be written in English and translated into each of the local language (sample attached in the Annex).
Prior to the trial in the selected study sites, public meetings will be held with the parents/guardians, community leaders and teachers, where the purpose of the trial, safety precautions and benefits for the study population will be explained by qualified study staff. It will be emphasized that participation in the trial is entirely voluntary; neither the parents/guardians nor their children will be discriminated against in any way if they choose not to enter their children into the trial. Prior to agreement to enrol their children in the trial, parents/guardians will be given every opportunity to have their questions answered. Then the parents/guardians will be asked to sign the informed consent document. After signing, one copy of the document will be given to the parent/guardian, while the other will be brought to the study site on the day of enrolment to verify that consent has been given.
Confidentiality
The information obtained during the conduct of this study will remain confidential. Disclosure of any of the data to third parties other than those allowed in the Informed Consent form will not be permitted. The results of the research study may be published, but subjects' names or identities will not be revealed. Records will remain confidential. To maintain confidentiality, the Senior Scientist will keep records in locked cabinets and the results of the tests will be coded to prevent identification of the volunteers. Access to data entered into computerized files will permitted only for authorized personnel directly involved with the study and will be password protected. Subject-specific information may be provided to responsible local medical personnel only with the subject's permission. Stool samples collected will not be used for research purposes other than those outlined in the protocol, and will be safely disposed of after the completion of the study.
Feed-back after the trial has been completed
At the end of the trial, the results of the study will be communicated to the Ministry of Health (MoH) of each study site. In addition, the MoH and Ministry of Education (MoE) officers in charge of the districts where the study had been performed will inform the community of the results through the most appropriate channel, for example, a newsletter or a public meeting. The Department of Control of Neglected Tropical Disease at WHO, Geneva, will coordinate the international dissemination of the study results, including publication.
Safety
This trial will only use original albendazole product that has already been approved by the National Regulatory authority of each country in which the trial will be carried out. It is recognized that all study sites have been regularly using albendazole or mebendazole in National mass deworming campaigns. The drugs will only be administered by qualified health professionals as outlined in the study protocol. Although treatment with albendazole has been ongoing as a Public Health intervention, and the safety of the drug in the study group has been well demonstrated, referral to appropriate medical professionals will be made available for any rare but possible severe adverse event occurring during the study will be provided by the study team.
Benefits
Children participating in the trial will directly benefit by being investigated for STH infections and receiving appropriate treatment. Children still infected at the end of the observation period will immediately be offered additional treatment according of their specific clinical situation. The study results will help to guide WHO and the international scientific community in choosing the most effective protocol to monitor anthleminthic efficacy, and will also guide global recommendations for STH endemic countries.
Annex 2
Parasitological techniques Annex 2.1 -McMaster technique
The McMaster technique uses a counting chamber which enables a known volume of faecal suspension (2 x 0.15 ml) to be examined microscopically. Thus, if a known weight of faeces and a known volume of flotation fluid are used to prepare the suspension, then the number of eggs per gram of faeces (FEC) can be calculated. The quantities are chosen so that the faecal egg-count can be easily derived by multiplying the number of eggs under the marked areas by a simple conversion factor. The McMaster chamber has two compartments, each with a grid etched onto the upper surface. When filled with a suspension of faeces in flotation fluid, much of the debris will sink while eggs float to the surface, where they can easily be seen and those under the grid counted.
Equipment List * Two beakers or plastic containers * Balance * Tea strainer * Measuring cylinder * Stirring device (fork, spatula, tongue depressor) * Pasteur pipettes and rubber teats * Flotation fluid (density of 1.22): to be prepared at least one day before use and kept at temperatures > 20°C. The flotation fluid is a saturated salt solution, with a minimum of 333 g NaCl in 1L of aq dest; the presence of a salt sedimention confirms saturation * McMaster counting chamber * Compound microscope Procedure 1. Weigh 2 grams of faeces in a plastic beaker (100 ml). 2. Add 30 ml of the flotation fluid saturated salt solution, 3. Homogenise and pour the faecal suspension 3 times through a tea strainer to withhold the large debris. 4. Homogenise the filtrate by pouring it at least 5 times from one beaker to another and fill up one side of a regular McMaster counting chamber by using a pasteur pipette. Repeat for the other side. 5. Allow the counting chamber to stand for 2 minutes, place under a light microscope and examine using a 100x magnification. All the eggs under the two separate grids are counted (this represents a volume of 2x 0.15 ml) 6. The number of eggs per gram of faeces is obtained by multiplying the total number of eggs under the two grids by 50. The sensitivity of the test is 50.
9. Ascaris and Trichuris eggs will remain visible and recognizable for many months in these preparations. Hookworm eggs clear rapidly and will no longer be visible after 30-60 minutes. Schistosome eggs may be recognizable for up to several months but it is preferable in a schistosomiasis endemic area to examine the slide preparations within 24 hours. 10. The smear should be examined in a systematic manner and the number of eggs of each species reported. Later multiply by the appropriate number to give the number of eggs per gram of faeces (by 20 if using a 50 mg template; by 50 for a 20 mg template; and by 24 for a 41.7 mg template). With high egg counts, to maintain a rigorous approach while reducing reading time, the Stoll quantitative dilution technique with 0.1 mol/litre NaOH may be recommended (see Basic laboratory methods in medical parasitology, WHO, 1991) .
Annex 2.3 -Coproculture technique
To isolate infective stage hookworm larvae, feces are mixed with sufficient volume of water to enable homogenization by shaking in a sealed two liter container. An equal volume of vermiculite is then mixed with the faecal suspension. Further water is added until the mixture is uniformly moist. The mixture is incubated at 25-30 o C for 5-7 days, being stirred daily. [WEAR GLOVES FROM HERE ON] After five days, the mixture is spread onto large glass dishes such as Petri dishes, covered with a 5mm layer of washed, coarse river sand and overlaid with two layers of damp surgical gauze. The top layer of gauze (into which infective L3 migrate) is removed (and replaced) at 12 hour intervals, to be rinsed in distilled water. Larvae are retrieved from the suspension by gravitational sedimentation.
Optional: Viable larvae can be stored in BU buffer (50mM Na 2 HPO 4 , 22mM KH 2 PO 4 , 70mM NaCl) at 12 o C for some time to preserve their infectivity (Hawdon 1991). To reduce bacterial and fungal contamination amphotericin B (Fungizone BristolMeyersSquib 0.25µg.ml µg/ml) and ceftriaxone (Rocephin Roche Y 20 µg/ml can be added at the start of the culture.
